openPR Logo
Press release

Bioimpedance Analyzers Market to reach USD 1.375 million in 2031, growing at a rate of 12.1% from 2022 to 2031

07-26-2022 11:18 AM CET | Health & Medicine

Press release from: Global Insight Services

Bioimpedance Analyzers Market to reach USD 1.375 million

New York, The global bioimpedance analyzer market size was USD 439 million in 2021 ad is anticipated to reach USD 1.375 million in 2031, growing at a rate of 12.1% from 2022 to 2031.

Global Bioimpedance Analyzers Market report from Global Insight Services is the single authoritative source of intelligence on Bioimpedance Analyzers Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Read more about Bioimpedance Analyzers Market here: https://www.globalinsightservices.com/reports/bioimpedance-analyzers-market/

Bioimpedance measuring devices are used to measure the level of fluids in living tissue. These devices use electrical conductivity and reactance, which is a property of an object that opposes any change in the electric current flowing through it. This type of device can provide vital information regarding fluid buildup or dehydration for athletes and those with chronic health conditions like heart diseases.

Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10241/

Market Trends and Drivers
Unhealthy lifestyles, such as sedentary work environments, consumption of junk food, and increased mobility automation have increased the prevalence of certain lifestyle diseases, like obesity, high blood pressure, and diabetes. According to WHO, in 2019, an estimated 38.2 million children under the age of 5 were overweight or obese. Once considered a high-income country problem, overweight and obesity are now on the rise in low- and middle-income countries, particularly in urban settings. In Africa, the number of overweight children under 5 who were overweight or obese in 2019 lived in Asia. Owing to that, the increasing prevalence of lifestyle diseases is boosting the growth of the global bioimpedance analyzers market.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10241/

Global Bioimpedance Analyzers Market Segmentation
The report analyses the bioimpedance analyzers market based on product, modality, application, end-user, and regions.

Global Bioimpedance Analyzers Market by Product

On the basis of type, it is segmented into multi-frequency analyzers, single-frequency analyzers, and dual-frequency analyzers. The multi-frequency analyzers segment is likely to dominate the market during the forecast period. Multi-frequency bioelectrical impedance analysis (MF-BIA) may be a relatively simple, quick method to measure body composition, for instance, fat mass and fat-free mass, having the advantage of being portable, relatively cheap, and not requiring specialist training for use. The growth of this segment can be attributed to the increasing preference for multi-frequency bioimpedance analyzers is high among end-users as they are both segmental and whole-body measurements, unlike single-frequency bioimpedance analyzers.

Global Bioimpedance Analyzers Market by Modality

Based on modality, it is segmented into wired bioimpedance analyzers, and wireless bioimpedance analyzers. The wired bioimpedance analyzers are likely to dominate the market during the forecast period. The key factors boosting the market growth are the increasing prevalence of lifestyle diseases coupled with initiatives by governments and private organizations to promote healthy lifestyles is boosting the growth of the segment in the market. The impedance analyzer measures the difference between the maximum current and the minimum current, but also the time difference between the potential and the current wave-forms.

Global Bioimpedance Analyzers Market by Application

By application, it is segmented into whole-body measurement and segmental body measurement. The demand in the bioimpedance market for segmental body measurement is expected to grow significantly in the forecast period. The whole-body measurement is expected to hold a significant share of the market due to the increasing prevalence of obesity and metabolic disorders. Thus, the demand in the bioimpedance market would rise during the forecast period.

Global Bioimpedance Analyzers Market by End User

By end user, it is divided into fitness clubs and wellness centers, home users, hospitals, and others. The demand for bioimpedance analyzers in fitness clubs and wellness centers is expected to grow significantly during the forecast period. The increasing number of fitness clubs and wellness centers and the growing awareness about health and fitness across the globe are boosting the growth of the market.

Geographical Analysis of Global Bioimpedance Analyzers Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share of the bioimpedance analyzers market. The large share of North America can be attributed to factors such as the growing obesity rate, government initiatives to encourage healthy lifestyles, increasing use of body composition analyzers for assessing athlete fitness, and increasing number of health clubs and fitness centers.

Major Players of the Global Bioimpedance Analyzers Market
The global bioimpedance analyzers market report includes players such as Omron Corporation, Tanita Corporation, InBody, RJL Systems, seca GmbH & Co. KG, EVOLT 360, SELVAS Healthcare, Charder Electronic Co. Ltd., Fook Tin Group Holding Ltd., Bodystat Ltd., Maltron International, Biotekna, Withings, Biodynamics Corporation, Akern, Xiaomi, Sino-Hero (Shenzhen) Bio-Medical Electronics Co., Ltd., Lumsail Industrial Inc., Guangzhou Beautylife Electronic Technology Co., Ltd., Bioparhom.

Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10241/

With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bioimpedance Analyzers Market to reach USD 1.375 million in 2031, growing at a rate of 12.1% from 2022 to 2031 here

News-ID: 2690131 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for Bioimpedance

Bioimpedance Device Market: A Guide to Understanding the Process
The global Bioimpedance Device Market is estimated to be valued at USD 1.2 billion in 2024 and is anticipated to reach USD 2.8 billion by 2033, growing at a CAGR of 10.2% during the forecast period from 2025 to 2033. Bioimpedance Device Market Overview The Bioimpedance Device Market is witnessing steady growth driven by increasing applications in healthcare diagnostics, fitness monitoring, and body composition analysis. These devices measure electrical impedance to
Primary Catalyst Driving Bioimpedance Analyzers Market Evolution in 2025: Rising …
"What Is the Future Outlook for the Bioimpedance Analyzers Market's Size and Growth Rate? The market capacity of bioimpedance analyzers has expanded significantly over the past few years, with the projection to rise from $0.59 billion in 2024 to $0.67 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.5%. Factors contributing to the growth during the historical period include the escalating obesity crisis, evolving lifestyle trends, a surge
Bioimpedance Analyzers Market worth $927 million by 2028
Bioimpedance Analyzers Market in terms of revenue was estimated to be worth $564 million in 2023 and is poised to reach $927 million by 2028, growing at a CAGR of 10.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rising initiatives by government in promoting healthy lifestyle to curb obesity, growing number of gyms and wellness centers, strong
Bioimpedance Analyzers Market to reach USD 927 million by 2028
"The rise in obesity rate is expected to drive the demand of the market." The global bioimpedance analyzers market is projected to reach USD 927 million by 2028 from USD 564 million in 2023, at a CAGR of 10.4% during the forecast period. The growth of this market is majorly driven by the promotion of healthy lifestyles by the government, growing fitness and wellness centers, and an increase in the number
Bioimpedance Analyzers Market: Global Industry Analysis And Forecast 2023 - 2029
Market Overview: The Global Bioimpedance Analyzers market was valued at USD 465.58 million in 2021 and is expected to reach USD 836.45 million by the year 2028, at a CAGR of 8.73%. The screening instrument that can be used to measure and accurately analyze body composition and body fat is known as a bioimpedance analyzer (BIA). It is a non-invasive instrument that doctors use to calculate body fat percentage. Additionally, it enables
Single-frequency Bioimpedance Devicess Market: Competitive Dynamics & Global Out …
New report published by Market Research Report Store (MRRS) which offers insights on the global Single-frequency Bioimpedance Devicess market. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/242079/global-single-frequency-bioimpedance-devicess-market Global Single-frequency Bioimpedance Devicess Market: Forecast by Type / Application / Region According to this study, over the next five years the Single-frequency Bioimpedance Devicess market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million